Photocure ASA
Develops and commercializes photodynamic technology for bladder cancer.
PHO | OL
Overview
Corporate Details
- ISIN(s):
- NO0010000045
- LEI:
- 5967007LIEEXZXG8OW35
- Country:
- Norway
- Address:
- HOFFSVEIEN 4, 0275 OSLO
- Website:
- https://www.photocure.com/
- Sector:
- Manufacturing
Description
Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-03-20 07:00 |
Photocure: Hexvix® featured at the 2018 Annual European Association of Urology …
|
English | 6.9 KB | ||
| 2018-02-27 06:15 |
Photocure ASA: Results for the fourth quarter of 2017
|
English | 1.0 MB | ||
| 2018-02-27 06:15 |
Photocure ASA: Results for the fourth quarter of 2017
|
English | 992.0 KB | ||
| 2018-02-27 06:15 |
Photocure ASA: Results for the fourth quarter of 2017
|
English | 5.5 KB | ||
| 2018-02-20 09:54 |
Photocure ASA: Presentation of the fourth quarter and full year 2017 results
|
English | 2.1 KB | ||
| 2018-02-16 06:55 |
Photocure Announces U.S. FDA Approval of New Indications for Blue Light Cystosc…
|
English | 7.9 KB | ||
| 2018-01-30 07:30 |
Financial calendar
|
English | 693 bytes | ||
| 2018-01-08 07:30 |
Photocure to present at investor meetings in San Francisco
|
English | 1.2 MB | ||
| 2018-01-08 07:30 |
Photocure to present at investor meetings in San Francisco
|
English | 1.1 KB | ||
| 2017-12-13 09:55 |
Photocure ASA: Presentation at the DNB Nordic Healthcare Conference, Oslo
|
English | 1.5 KB | ||
| 2017-12-08 07:20 |
Photocure ASA: Landmark Blue Light Cystoscopy with Cysview® study is published …
|
English | 6.8 KB | ||
| 2017-12-05 12:02 |
Photocure ASA: Presentation at the Carnegie Nordic Healthcare Day, New York
|
English | 1.5 KB | ||
| 2017-12-01 07:32 |
Photocure ASA: Blue Light Flexible Cystoscopy with Cysview® Phase 3 study: New …
|
English | 6.3 KB | ||
| 2017-11-27 14:35 |
Financial calendar
|
English | 614 bytes | ||
| 2017-11-09 12:12 |
Photocure ASA: Clinical and cost impact analysis shows beneficial impact of rep…
|
English | 4.0 KB |
Automate Your Workflow. Get a real-time feed of all Photocure ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Photocure ASA
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Photocure ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
